No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection

Pathology

Volumn 41, Issue 6, 2009, Pages 555-560

  Qi, Peng ^a   Wang, Hao ^b   Chen, Yue Ming ^c   Sun, Xiao Juan ^a   Liu, Yan ^a   Gao, Chun Fang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Case control study; Chronic hepatitis; Epidermal growth factor; HBV; Hepatocellular carcinoma; Single nucleotide polymorphism

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADULT; ARTICLE; CHINESE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70350675946     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020903071603     Document Type: Article

References (33)

1. Srivatanakul P, Sriplung H, Deerasamee S. Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev 2004; 5: 118-125
2. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411: 390-395
3. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000; 14: 703-709
4. Ponder BA. Cancer genetics. Nature 2001; 411: 336-341
5. Lee HS, Yoon JH, Kamimura S, Iwata K, Watanabe H, Kim CY. Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma. Int J Cancer 1997; 71: 737-740
6. Yu MW, Chiu YH, Yang SY, et al. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer 1999; 80: 598-603.
7. Vogel A, Kneip S, Barut A, et al. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 2001; 121: 1136-1144
8. Yu MW, Pai CI, Yang SY, et al. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: Impact of smoking on risk. Gut 2000; 47: 703-709
9. Yu MW, Yang SY, Pan IJ, et al. Polymorphisms in XRCC1 and glutathione S transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 2003; 95: 1485-1488
10. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 1999; 29: 697-702.
11. Kim YJ, Lee HS, Im JP, et al. Association of transforming growth factor beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 2003; 35: 196-202.
12. Shin HD, Park BL, Kim LH, et al. Interleukin-10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 2003; 12: 901-906
13. Morton CC, Byers MG, Nakai H, Bell GI, Shows TB. Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22-q24.1, 11p15, and 4q25-q27, respectively. Cytogenet Cell Genet 1986; 41: 245-249
14. Normanno N, De Luca A, Bianco C, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006; 366: 2-16.
15. Fisher DA, Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 1990; 11: 418-442
16. Laurence DJR, Gusterson BA. The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells. Tumor Biol 1990; 11: 229-261
17. Shahbazi M, Pravica V, Nasreen N, et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 2002; 359: 397-401.
18. Costa BM, Ferreira P, Costa S, et al. Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res 2007; 13: 2621-2626
19. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 2004 15; 64: 1220-1223
20. Okamoto I, Roka F, Krögler J, et al. The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. J Invest Dermatol 2006; 126: 2242-2246
21. Hamai Y, Matsumura S, Matsusaki K, et al. A single nucleotide polymorphism in the 50 untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology 2005; 72: 133-138
22. Lim YJ, Kim JW, Song JY, et al. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett 2005; 374: 157-160
23. Tanabe KK, Lemoine A, Finkelstein DM, et al. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 2008; 299: 53-60.
24. Vishnoi M, Pandey SN, Modi DR, Kumar A, Mittal B. Genetic susceptibility of epidermal growth factor +61A4G and transforming growth factor beta1 7509C4T gene polymorphisms with gallbladder cancer. Hum Immunol 2008; 69: 360-367
25. Lanuti M, Liu G, Goodwin JM, et al. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res 2008; 14: 3216-3222
26. McCarron SL, Bateman AC, Theaker JM, Howell WM. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer 2003; 107: 673-675
27. Amend KL, Elder JT, Tomsho LP, et al. EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res 2004; 64: 2668-2672
28. Randerson-Moor JA, Gaut R, Turner F, et al. The relationship between the epidermal growth factor (EGF) 50UTR variant A61G and melanoma/nevus susceptibility. J Invest Dermatol 2004; 123: 755-759
29. James MR, Hayward NK, Dumenil T, Montgomery GW, Martin NG, Dufiy DL. Epidermal growth factor gene (EGF) polymorphism and risk of melanocytic neoplasia. J Invest Dermatol 2004; 123: 760-762
30. Goto Y, Ando T, Goto H, Hamajima N. No association between EGF gene polymorphism and gastric cancer. Cancer Epidemiol Biomark Prev 2005; 14: 2454-2456
31. Anttila S, Illi A, Kampman O, Mattila KM, Lehtimaki T, Leinonen E. Association of EGF polymorphism with schizophrenia in Finnish men. Neuroreport 2004; 15: 1215-1218
32. Lim YJ, Kim JW, Song JY, et al. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett 2005; 374: 157-160
33. Watanabe Y, Fukui N, Muratake T, Kaneko N, Someya T. No association of EGF polymorphism with schizophrenia in a Japanese population. Neuroreport 2005; 16: 403-405